The association of survival with adjuvant chemotherapy in patients with ypTNM stage I gastric cancer after neoadjuvant chemotherapy

Key Points

• The research aims to determine the impact of adjuvant chemotherapy on survival in patients with ypTNM stage I gastric cancer after neoadjuvant chemotherapy.
• Analyzed data from patients with ypTNM stage I gastric cancer.
• Compared outcomes between those receiving adjuvant chemotherapy and those who did not.
• Utilized nomograms to assess predictive value for patient prognosis.
• Postoperative adjuvant chemotherapy was associated with better survival outcomes.
• Nomograms effectively predicted prognosis for patients who received adjuvant chemotherapy.